Biochemical aspects of the hyperglycemic action of diazoxide.
D000311:Adrenal Glands / Q000187:drug effects; D000818:Animals; D001786:Blood Glucose / Q000378:metabolism; D001794:Blood Pressure / Q000187:drug effects*; D002395:Catecholamines / Q000378:metabolism; D000242:Cyclic AMP / Q000378:metabolism; D003981:Diazoxide / Q000494:pharmacology*; D005952:Glucose-6-Phosphatase / Q000378:metabolism; D006019:Glycolysis / Q000502:physiology; D006943:Hyperglycemia / Q000139:chemically induced*; D007328:Insulin / Q000378:metabolism*; D000078790:Insulin Secretion; D007515:Islets of Langerhans / Q000187:drug effects; D010744:Phosphoric Monoester Hydrolases / Q000378:metabolism*; D011191:Potassium Deficiency / Q000378:metabolism; D051381:Rats
D001786:Blood Glucose; D002395:Catecholamines; D007328:Insulin; D000242:Cyclic AMP; D010744:Phosphoric Monoester Hydrolases; D005952:Glucose-6-Phosphatase; D003981:Diazoxide